Analysis – Goldea Capital

Vesicor Therapeutics Appoints Michael Tolentino, M.D., as Chief Executive Officer

Written by Customer Service on March 19, 2026. Posted in Public Companies.

BLACKHAWK, Calif., March 18, 2026 (GLOBE NEWSWIRE) — Vesicor Therapeutics, Inc., a San Gabriel, California-based early development stage biotechnology corporation focused on the development of p53-based cancer therapeutics delivered via precision-engineered microvesicles and a proposed de-SPAC acquisition target for Black Hawk Acquisition Corporation (Nasdaq: BKHA, BKHAU, BKHAR), today announced that its Board of Directors has appointed Michael Tolentino, M.D., an accomplished biotech leader with deep industry experience, as Chief Executive Officer (CEO), effective March 17, 2026. He succeeds Founder and CEO Luo Feng, Ph.D., who has been appointed Chief Scientific Officer. “Dr. Tolentino is an exceptional leader whose biotech industry expertise, deep relationships across the contract research organization (CRO) and pharma ecosystems...

Smallcap World Fund Inc. Acquires Common Shares of Altus Group Limited

Written by Customer Service on March 19, 2026. Posted in Mergers And Acquisitions.

LOS ANGELES, March 18, 2026 (GLOBE NEWSWIRE) — Smallcap World Fund Inc. (“SCWF”) announces that on March 18, 2026 it acquired an aggregate of 141,502 common shares (the “Purchased Shares”) of Altus Group Limited (“Altus”) through the facilities of the Toronto Stock Exchange. Immediately following the acquisition of the Purchased Shares, SCWF had control or direction over an aggregate of 3,037,322 common shares of Altus representing approximately 7.6572% of the 39,666,476 Altus common shares outstanding (net of 191,057 escrowed common shares). SCWF has not acquired any Altus securities other than the Purchased Shares since the commencement of Altus’ substantial issuer bid. The Purchased Shares were acquired in the ordinary course of SCWF’s investment management business. SCWF may, in the future and from time to time, acquire or dispose...

Abaxx Joins Singapore Bullion Market Association

Written by Customer Service on March 19, 2026. Posted in Public Companies.

TORONTO and SINGAPORE, March 18, 2026 (GLOBE NEWSWIRE) — Abaxx Technologies Inc. (CBOE:ABXX)(OTCQX:ABXXF) (“Abaxx” or the “Company”), a financial software and market infrastructure company, indirect majority shareholder of Abaxx Singapore Pte Ltd. (“Abaxx Singapore”), the owner of Abaxx Commodity Exchange and Clearinghouse (individually, “Abaxx Exchange” and “Abaxx Clearing”), today announced that Abaxx Singapore has joined the Singapore Bullion Market Association (“SBMA”) as a Local Associate Member. The Singapore Bullion Market Association (SBMA) is a non-profit, member-driven industry body representing participants across the precious metals value chain, including bullion banks, exchanges, refineries, trading firms, and logistics providers. It convenes the key institutions that underpin Singapore’s position as a regional hub...

RYVYL Inc. Announces Postponement of Special Meeting of Shareholders

Written by Customer Service on March 19, 2026. Posted in Public Companies.

Approximately 99% of Shareholder Votes Cast to Date are in Favor of Proposed Merger between RYVYL and Roundtable SAN DIEGO, CA, March 18, 2026 (GLOBE NEWSWIRE) — RYVYL Inc. (NASDAQ: RVYL) (“RYVYL” or the “Company”) today announced that the Special Meeting of Shareholders (the “Special Meeting”) to vote on the Company’s planned merger with RTB Digital, Inc. (“Roundtable”), which was convened on March 18, 2026, has been adjourned, to reconvene virtually on March 25, starting at 4pm EST. Shareholders interested in participating in the reconvened Special Meeting should use the following link: http://www.virtualshareholdermeeting.com/RVYL2026SM The record date for the Special Meeting, February 6, 2026, is unchanged and applies to the reconvened Special Meeting. To date, approximately 99% of the votes cast, voted in favor of the proposed...

ROHM to Showcase Cutting-Edge Power Electronics Solutions at APEC 2026

Written by Customer Service on March 19, 2026. Posted in Public Companies.

Visit ROHM at APEC 2026 Booth #1443ROHM will be showcasing its latest technologies for a wide range of applications.Santa Clara, CA and Kyoto, Japan, March 18, 2026 (GLOBE NEWSWIRE) — ROHM Semiconductor U.S.A., LLC today announced its participation at APEC 2026, the premier event for the power electronics community. This year’s conference will be held at the Henry B. Gonzalez Convention Center in San Antonio, TX, from March 22–26. At Booth 1443, attendees can explore ROHM’s latest technologies designed to enhance efficiency, performance, and reliability across a wide range of applications. Interactive product demos will highlight ROHM’s latest breakthroughs and collaboration examples in Silicon Carbide (SiC) and Gallium Nitride (GaN) – technologies driving the evolution of automotive and EV, industrial power, and consumer...

The Honest Company to Participate in 38th Annual ROTH Conference on March 23, 2026

Written by Customer Service on March 19, 2026. Posted in Public Companies.

LOS ANGELES, March 18, 2026 (GLOBE NEWSWIRE) — The Honest Company (NASDAQ: HNST), a personal care company dedicated to creating cleanly-formulated and sustainably-designed products for everyone from babies to adults, today announced that Chief Financial Officer, Curtiss Bruce and Interim Head of Investor Relations, Chris Mandeville will participate in investor meetings at the 38th Annual ROTH Conference in Dana Point, California on Monday, March 23rd, 2026. About The Honest Company Founded in 2012, The Honest Company (NASDAQ: HNST) is on a mission to create personal care that raises the standards of clean and brings joy to each and every moment. By combining thoughtful design with science-based innovation, the Company delivers cleanly-formulated and sustainably-designed personal care products for everyone from babies to adults –...

BHAV Acquisition Corp Announces Pricing of $100 Million Initial Public Offering

Written by Customer Service on March 19, 2026. Posted in Public Companies.

PISCATAWAY, N.J., March 18, 2026 (GLOBE NEWSWIRE) — BHAV Acquisition Corp (the “Company” or “BHAV”) today announced the pricing of its initial public offering of 10,000,000 units at an offering price of $10.00 per unit, with each unit consisting of one Class A ordinary share and one right. Each right entitles the holder to receive one-fourth (1/4) of one Class A ordinary share upon consummation of the Company’s initial business combination. In connection with the offering, $10.00 per unit will be deposited into a trust account with Continental Stock Transfer & Trust Company acting as trustee. The units are expected to trade on the Nasdaq Global Market (“Nasdaq”) under the ticker symbol “BHAVU” beginning on March 19, 2026. Once the securities comprising the units begin separate trading, the Class A ordinary shares and rights...

Purpose Investments Inc. Announces March 2026 Distributions

Written by Customer Service on March 18, 2026. Posted in Dividend Reports And Estimates.

TORONTO, March 18, 2026 (GLOBE NEWSWIRE) — Purpose Investments Inc. (“Purpose”) is pleased to announce distributions for the month of March 2026 for its open-end exchange-traded funds and closed-end funds (“the Funds”). The ex-distribution date for all Open-End Funds is March 27, 2026. The ex-distribution date for all closed-end funds is March 31, 2026. Open-End Funds Ticker Symbol Distribution per share/unit Record Date Payable Date Distribution FrequencyApple (AAPL) Yield Shares Purpose ETF – ETF Units APLY $0.1667 03/27/2026 04/02/2026 MonthlyPurpose Couche-Tard (ATD) Yield Shares ETF – ETF Series ATDY $0.0650 03/27/2026 04/02/2026 MonthlyPurpose Canadian Financial Income Fund – ETF Series BNC $0.1225¹ 03/27/2026 04/02/2026 MonthlyPurpose Global Bond Fund – ETF Units BND $0.0866 03/27/2026 04/02/2026 MonthlyPurpose...

Positive VAX-31 Phase 1/2 Adult Data Published in The Lancet Infectious Diseases Highlight Best-in-Class Potential of Vaxcyte’s 31-Valent Pneumococcal Conjugate Vaccine (PCV) Candidate

Written by Customer Service on March 18, 2026. Posted in Public Companies.

Based on the Strength of Unprecedented Results from the Positive Phase 1/2 Study in Adults Aged 50 and Older, Vaxcyte Advanced VAX-31 High Dose into Comprehensive Phase 3 Adult Program; Topline Data from the OPUS-1 Pivotal Noninferiority Trial Expected in the Fourth Quarter of 2026 At All Doses Studied, VAX-31 Demonstrated Robust Opsonophagocytic Activity and Immunoglobulin G Immune Responses for All 31 Serotypes and Was Observed to be Well Tolerated with a Safety Profile Similar to Prevnar 20® Results Further Validate Potential of Vaxcyte’s Carrier-Sparing Platform to Deliver Broadest-Spectrum PCV Candidates that Provide Protection Against Both Currently Circulating and Historically Prevalent Serotypes VAX-31 is Designed to Cover ~95% of Invasive Pneumococcal Disease (IPD) and ~88% of Pneumococcal Pneumonia in U.S. Adults Aged 50 and...

Preferred Bank Announces Quarterly Dividend

Written by Customer Service on March 18, 2026. Posted in Dividend Reports And Estimates.

LOS ANGELES, March 18, 2026 (GLOBE NEWSWIRE) — Preferred Bank (NASDAQ: PFBC), one of the larger independent commercial banks in California, today reported that the Board of Directors has declared a quarterly cash dividend of $0.80 per share, payable on April 21, 2026 to holders of record on April 7, 2026. About Preferred Bank Preferred Bank is one of the larger independent commercial banks headquartered in California. The Bank is chartered by the State of California, and its deposits are insured by the Federal Deposit Insurance Corporation, or FDIC, to the maximum extent permitted by law. The Bank conducts its banking business from its main office in Los Angeles, California, and through twelve full-service branch banking offices in California (Alhambra, Century City, City of Industry, Torrance, Arcadia, Irvine (2), Diamond Bar,...

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals